REZŪM vs. Dual Drug Therapy for Symptomatic Benign Prostatic Hyperplasia in Sexually Active Men
Clinical trial NCT04838769 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT04838769
- Sponsor
- Boston Scientific Corporation
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Start date
- 2021-09-15
- Primary completion
- 2025-12-11
- Enrollment
- 155
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.